129 related articles for article (PubMed ID: 23439579)
1. Learning and cognitive fatigue trajectories in multiple sclerosis defined using a burst measurement design.
Holtzer R; Foley F; D'Orio V; Spat J; Shuman M; Wang C
Mult Scler; 2013 Oct; 19(11):1518-25. PubMed ID: 23439579
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
3. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
4. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
5. How to detect cognitive dysfunction at early stages of multiple sclerosis?
Deloire MS; Bonnet MC; Salort E; Arimone Y; Boudineau M; Petry KG; Brochet B
Mult Scler; 2006 Aug; 12(4):445-52. PubMed ID: 16900758
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
7. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
[TBL] [Abstract][Full Text] [Related]
9. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
[TBL] [Abstract][Full Text] [Related]
10. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
[TBL] [Abstract][Full Text] [Related]
11. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
Yu HJ; Christodoulou C; Bhise V; Greenblatt D; Patel Y; Serafin D; Maletic-Savatic M; Krupp LB; Wagshul ME
Neuroimage; 2012 Feb; 59(4):3713-22. PubMed ID: 22062194
[TBL] [Abstract][Full Text] [Related]
12. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
[TBL] [Abstract][Full Text] [Related]
13. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
[TBL] [Abstract][Full Text] [Related]
14. Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Sundgren M; Wahlin Å; Maurex L; Brismar T
J Neurol Sci; 2015 Sep; 356(1-2):107-12. PubMed ID: 26117361
[TBL] [Abstract][Full Text] [Related]
15. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
[TBL] [Abstract][Full Text] [Related]
16. Symptom cluster and physical activity in relapsing-remitting multiple sclerosis.
Motl RW; Weikert M; Suh Y; Dlugonski D
Res Nurs Health; 2010 Oct; 33(5):398-412. PubMed ID: 20725947
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
J Neurol Sci; 2013 Nov; 334(1-2):154-60. PubMed ID: 24011606
[TBL] [Abstract][Full Text] [Related]
18. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.
Amato MP; Portaccio E; Goretti B; Zipoli V; Iudice A; Della Pina D; Malentacchi G; Sabatini S; Annunziata P; Falcini M; Mazzoni M; Mortilla M; Fonda C; De Stefano N;
Mult Scler; 2010 Dec; 16(12):1474-82. PubMed ID: 20729256
[TBL] [Abstract][Full Text] [Related]
19. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
20. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
Patti F; Amato MP; Bastianello S; Caniatti L; Di Monte E; Ferrazza P; Goretti B; Gallo P; Morra VB; Lo Fermo S; Picconi O; Tola MR; Trojano M;
Mult Scler; 2010 Jan; 16(1):68-77. PubMed ID: 19995846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
